Alchemab’s CEO Young Kwon has appeared on the leading pharma website pharmaphorum outlining the company’s revolutionary approach to antibody technology. In the podcast, Kwon outlined how Cambridge, UK-based Alchemab wants to find a new generation of antibody drugs using a novel approach. The company is searching through the entire antibody repertoire of the human body […]
More than hangover-busting aspirin will be in order at the biopharma industry’s biggest week in London. The capital will host a gruelling conference double header, beginning with the LSX Inv€$tival Showcase on Monday 13th November, followed by the Jefferies London Healthcare Conference on Tuesday 14th November. With investors and biopharma business leaders descending on the […]
In the latest podcast episode, Optimum Strategic Communications’ Eva Haas gives her thoughts on the trends in the biopharma market for 2023. After the geopolitical upheavals of last year, according to some sources there has been a gradual recovery. For instance an analysis by Clarivate and the BioIndustry Association trade body secured £382 million in […]
• Etienne Fradet brings extensive industry expertise and a successful track record in bringing innovative microfluidic technologies to market • Appointment strengthens Astraveus’ position in the CGT manufacturing field as it looks to develop and commercialise its Lakhesys platform Paris, France, 31 August, 2023 – Astraveus SAS (“Astraveus” or the “Company”), the creator of modular, […]
OSLO, Norway, August 31 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, today releases its first half and second quarter 2023 results. Chief Executive Officer of Lytix Biopharma, Dr. Øystein Rekdal, commented: “We have continued to make positive progress as we build a clinical Phase II […]
